Adjuvant treatment for triple negative breast cancer with residual tumor after neo-adjuvant chemotherapy. A single institutional retrospective analysis

PURPOSE: Incomplete response to neoadjuvant chemotherapy (NACT) in triple negative breast cancer (TNBC) patients is correlated to high risk of relapse. This study aimed to evaluate the role of adjuvant chemotherapy in TNBC with residual tumor after NACT. METHODS: We retrospectively reviewed the outc...

Descripción completa

Detalles Bibliográficos
Autores principales: Bianco, Nadia, Palazzo, Antonella, Pagan, Eleonora, Bagnardi, Vincenzo, Milano, Monica, De Maio, Ana Paula, Colleoni, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377481/
https://www.ncbi.nlm.nih.gov/pubmed/34407499
http://dx.doi.org/10.1016/j.breast.2021.08.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377481/
https://www.ncbi.nlm.nih.gov/pubmed/34407499
http://dx.doi.org/10.1016/j.breast.2021.08.004

Ejemplares similares